HomeFGEN • NASDAQ
add
FibroGen Inc
Previous close
$5.71
Day range
$5.27 - $5.77
Year range
$4.50 - $38.25
Market cap
21.42M USD
Avg Volume
45.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.74M | -89.20% |
Operating expense | 8.11M | -51.50% |
Net income | 4.64M | 114.09% |
Net profit margin | 169.37 | 230.45% |
Earnings per share | 1.25 | 115.15% |
EBITDA | -14.47M | 70.09% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.61M | -81.08% |
Total assets | 165.21M | -54.84% |
Total liabilities | 340.14M | -38.38% |
Total equity | -174.93M | — |
Shares outstanding | 4.04M | — |
Price to book | -0.11 | — |
Return on assets | -19.48% | — |
Return on capital | 41.75% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 4.64M | 114.09% |
Cash from operations | 2.72M | 104.59% |
Cash from investing | -16.00K | -100.03% |
Cash from financing | -88.00K | 46.67% |
Net change in cash | 4.02M | 150.57% |
Free cash flow | -36.30M | -96.53% |
About
Founded
Jan 1, 1993
Headquarters
Website
Employees
225
